LB PHARMACEUTICALS INC — Director's Dealing 2025

Sep 11, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LB PHARMACEUTICALS INC (LBRX)
CIK: 0001691082
Period of Report: 2025-09-10

Reporting Person: RUFFOLO ROBERT R (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2365	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$69.72	2028-06-26	Common Stock (1792)		Direct
Stock Option (Right to Buy)	$69.72	2030-08-24	Common Stock (717)		Direct
Stock Option (Right to Buy)	$41.84	2034-03-03	Common Stock (10757)		Direct

Footnotes

F1: Includes 1,792 shares of restricted stock which shall vest six months from the closing date of the Issuer's initial public offering.

F2: Immediately exercisable.

F3: One fourth (1/4) of the shares subject to the option award vested on March 4, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.